IDO1 and colorectal carcinoma: In CRC patients, dysbiosis with increasing Enterococcus faecalis and Escherichia coli influences the production of the intestinal inflammatory signalling molecules IFN-γ and IL-4, converting the expression of IDO1 and altering tryptophan metabolism [127].